Principal Securities’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-290
Closed -$32.5K 3315
2025
Q3
$32.5K Buy
290
+271
+1,426% +$31.7K ﹤0.01% 2170
2025
Q2
$2.55K Buy
+19
New +$2.09K ﹤0.01% 3065
2024
Q4
Sell
-8
Closed -$1.26K 3627
2024
Q3
$1.26K Buy
8
+7
+700% +$1.08K ﹤0.01% 3085
2024
Q2
$151 Sell
1
-1
-50% -$120 ﹤0.01% 3333
2024
Q1
$148 Hold
2
﹤0.01% 3265
2023
Q4
$158 Buy
+2
New +$121 ﹤0.01% 3158

Other funds holding TMDX

Principal Securities's TMDX Position: Q4 2025 in Review

Principal Securities sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 290 shares — an estimated $32.5K sold.

Principal Securities first reported a position in TMDX in Q4 2023 and held it in 6 quarters. The position peaked at $32.5K in Q3 2025. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

  • Principal Securities reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 290 Transmedics shares in Q4 2025, an estimated $32.5K.
  • Principal Securities first reported a position in Transmedics in Q4 2023 and held it in 6 quarters.
  • Principal Securities's Transmedics position peaked at $32.5K in Q3 2025.
  • 428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.